[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2021.06.20.191Pharm Sci Asia 2021; 48(6), 576-583
 

Detection and differentiation of carbapenemase production in carbapenem-resistant Enterobacteriaceae by the novel modified Carba NP test

Bore Kong1, Farida Noothong2, Panyupa Pankhong3, Pitak Santanirand4, Noppadon Jumroon3*

1 Master of Science in Medical Technology Program, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand
2 Master of Science in Biomedical Sciences Program, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand
3 Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand and Integrative Biomedical Research Unit (IBRU)
4 Microbiology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand


There is an increasing worldwide prevalence of carbapenems resistance in Enterobacteriaceae (CRE). The production of carbapenemase is the most important drug resistance mechanism. Several phenotypic-based detecting carbapenemase enzyme methods have been developed, including the modified Hodge test (MHT), the Carba NP test, the modified carbapenem inactivation method (mCIM), and other combined disk tests. Unfortunately, these methods are unable to differentiate between types of carbapenemase. The purpose of this study was to develop and verify the modified Carba NP test for carbapenemase enzymes differentiation by supplementing the carbapenemase inhibitors (clavulanic acid and dipicolinic acid). The clinical isolates of carbapenemase-producing Enterobacteriaceae were collected from Wichianburi and Phetchabun hospitals in Phetchabun province, Thailand. These clinical isolates were then determined using phenotypic and genotypic methods. The results show that the novel modified Carba NP test showed 100% specificity. Non-susceptible carbapenem was detected in 28/173 isolates (16.2) of Enterobacteriaceae, and only 5 isolates (2.9%) of carbapenemase-producing Enterobacteriaceae were found. Genotypic analysis shows that these isolates habour the blaNDM of carbapenemase genes. Furthermore, the modified Carba NP test is considered to be an accessible method for identifying types of carbapenemase enzymes by using a microtiter plate, and the results can be interpreted within 15 and 90 minutes.


Keyword:

Carbapenem-resistant Enterobacteriaceae (CRE), Carbapenemase, Enterobacteriaceae, Carba NP test, Modified Carba NP test




Download full paper (PDF File size: 1,366.39 KB.)





Vol.48
No.6
November-December 2021

See other volume

 


Vol.48
No.5
September - October 2021

See other volume

 


Vol.48
No.4
July - August 2021

See other volume

 


Vol.48
No.3
May - June 2021

See other volume

 


Vol.48
No.2
March - April 2021

See other volume

 


Vol.48
No.1
January - February 2021

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017
    Faculty of Pharmacy, Mahidol University, THAILAND